BioSpace News Archive

Camurus AB announced that the Swiss agency for therapeutic products, Swissmedic, has approved weekly and monthly Buvidal® prolonged release buprenorphine for the treatment of opioid dependence in adults and adolescents from 16 years of age.

Taiwan has been lauded by international communities for its standout performance in containing the outbreak of the coronavirus.

Antengene Corporation Limited announced that the National Medical Products Administration has approved the Investigational New Drug application for ATG-010, an oral Selective Inhibitor of Nuclear Export compound, in combination with bortezomib and dexamethasone for the treatment of patients with relapsed/refractory multiple myeloma in China.

BioTelemetry, Inc., the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced that they have entered into a definitive merger agreement with Royal Philips.

Novaremed AG, a clinical-stage Swiss biopharmaceutical company, announced that it has received Fast Track Designation from the U.S. Food and Drug Administration for the development of NRD135S.E1 for the treatment of Painful Diabetic Peripheral Neuropathy.

Medtecs Group, a leading personal protective equipment supplier based in Taiwan, had passed the rigorous procurement process of the Asian Development Bank in June 2020 to become the ADB’s supplier of critical protective gear for frontline health workers risking their lives in the fight against the novel coronavirus.

Centene Corporation announced its 2021 financial guidance. Total revenues are expected to be $114.1 billion to $116.1 billion, and diluted earnings per share are expected to be $3.82 to $4.06.

The Access SARS-CoV-2 Antigen assay is offered to healthcare providers at $4, making reliable and frequent mass testing affordable

Sanofi Canada announced that Health Canada has approved expanded use of SOLIQUA®.

The Prix Galien Award, considered an equivalent of the Nobel Prize in biopharmaceutical research and medical technology research, has honoured Germitec’s Hypernova Chronos as the Best Medical Device for 2020.